Read on for article

Australian Friends of Rambam as part of its Meet the Experts program are to host a live webinar in collaboration with the Australia-Israel Chamber of Commerce, Israel Embassy and Zionism Victoria to discuss MesenCure.

The Israeli Ministry of Health confirmed on Wednesday, August 11, that hospitals will begin treating critically ill COVID-19 patients with a new drug developed in Israel called “MesenCure“, manufactured by Bonus BioGroup. The decision was made after recent clinical trials with the experimental drug at Rambam, with good results: 14 out of 16 seriously ill COVID-19 patients treated with the drug were discharged from the hospital. More details about this are available here.

The registration link to the webinar which will be recorded is

Speakers will be

* Moderator: Dr. Adir Shiffman

* Professor Marylouise McLaws – Professor of Epidemiology, Hospital Infection and Infectious Diseases Control, UNSW

* Dr Michelle Ananda-Rajah MBBS (HONS), FRACP, PhD -An infectious diseases and general physician at Alfred Health